Literature DB >> 12535738

Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells.

José Luis Sánchez-Quesada1, Mercedes Camacho, Rosa Antón, Sonia Benítez, Lluis Vila, Jordi Ordóñez-Llanos.   

Abstract

Electronegative LDL (LDL(-)) constitutes a plasma subfraction of LDL with proinflammatory properties. Its proportion is increased in familial hypercholesterolemia (FH); however, the characteristics of LDL(-) isolated from FH subjects have not been previously studied. In this work, the composition, oxidative status, and inflammatory capacity on endothelial cells of LDL(-) from FH and normolipemic (NL) subjects were evaluated. LDL(-) from FH was relatively enriched in esterified and free cholesterol and triglyceride, and had lower apoB and phospholipid content compared with the non-electronegative fraction (LDL(+)). LDL(-) also contained increased amounts of apoE, apoC-III, sialic acid, and non-esterified fatty acids (NEFAs). The same was observed in NL subjects, except that esterified cholesterol and phospholipid were similar in LDL(-) and LDL(+). No difference was observed between the two fractions concerning malondialdehyde, fatty acid hydroxides, and antioxidants, thereby indicating the absence of increased oxidation of LDL(-) compared with LDL(+). When LDL(-) (100 mg/l) from NL and FH subjects was incubated for 24 h with human umbilical vein endothelial cells (HUVECs), interleukin 8 (IL-8) and monocyte chemotactic protein 1 (MCP-1) increased twofold in the culture medium compared with LDL(+). Vascular cell adhesion molecule 1 (VCAM-1) expression was not increased by LDL(-). Our data indicate that LDL(-) from FH or NL subjects shows no evidence of increased oxidative modification compared to LDL(+); however, LDL(-) induces twofold the release of chemokines by endothelial cells. This effect, which may contribute to leukocyte recruitment and promote atherogenesis, may be greater in FH subjects in which LDL(-) can be up to eightfold higher than in NL subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535738     DOI: 10.1016/s0021-9150(02)00374-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  21 in total

1.  Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk.

Authors:  Ana Paula de Queiroz Mello; Isis Tande da Silva; Aline Silva Oliveira; Valéria Sutti Nunes; Dulcineia Saes Parra Abdalla; Magnus Gidlund; Nágila Raquel Teixeira Damasceno
Journal:  Lipids       Date:  2010-06-24       Impact factor: 1.880

2.  HDL and electronegative LDL exchange anti- and pro-inflammatory properties.

Authors:  Cristina Bancells; José Luis Sánchez-Quesada; Ragnhild Birkelund; Jordi Ordóñez-Llanos; Sònia Benítez
Journal:  J Lipid Res       Date:  2010-07-20       Impact factor: 5.922

3.  Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans.

Authors:  Cristina Bancells; Sònia Benítez; Jordi Ordóñez-Llanos; Katariina Öörni; Petri T Kovanen; Ross W Milne; José L Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

4.  Negatively charged low-density lipoprotein is associated with atherogenic risk in hypertensive patients.

Authors:  Jungo Urata; Satoshi Ikeda; Seiji Koga; Tomoo Nakata; Tomohiko Yasunaga; Koichiro Sonoda; Yuji Koide; Naoto Ashizawa; Shigeru Kohno; Koji Maemura
Journal:  Heart Vessels       Date:  2011-04-14       Impact factor: 2.037

5.  Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study.

Authors:  Bo Zhang; Akira Matsunaga; David L Rainwater; Shin-Ichiro Miura; Keita Noda; Hiroaki Nishikawa; Yoshinari Uehara; Kazuyuki Shirai; Masahiro Ogawa; Keijiro Saku
Journal:  J Lipid Res       Date:  2008-12-03       Impact factor: 5.922

6.  Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion.

Authors:  Cristina Bancells; Sandra Villegas; Francisco J Blanco; Sonia Benítez; Isaac Gállego; Lorea Beloki; Montserrat Pérez-Cuellar; Jordi Ordóñez-Llanos; José Luis Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

7.  The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.

Authors:  J L Sánchez-Quesada; S Benítez; A Pérez; A M Wagner; M Rigla; G Carreras; L Vila; M Camacho; R Arcelus; J Ordóñez-Llanos
Journal:  Diabetologia       Date:  2005-08-18       Impact factor: 10.122

8.  2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles.

Authors:  Francisco J Blanco; Sandra Villegas; Sònia Benítez; Cristina Bancells; Tammo Diercks; Jordi Ordóñez-Llanos; José L Sánchez-Quesada
Journal:  J Lipid Res       Date:  2010-01-28       Impact factor: 5.922

Review 9.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

10.  Dual roles for lipolysis and oxidation in peroxisome proliferation-activator receptor responses to electronegative low density lipoprotein.

Authors:  Ouliana Ziouzenkova; Liana Asatryan; Deanna Sahady; Gabriela Orasanu; Stephan Perrey; Benjamin Cutak; Tom Hassell; Taro E Akiyama; Joel P Berger; Alex Sevanian; Jorge Plutzky
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.